Equity Insights offers research and perspectives from Putnam’s equity team on market trends and opportunities.
This month’s authors: Richard E. Bodzy and Gregory D. McCullough, CFA, Portfolio Managers
The growth themes in our portfolio generate a lot of interest from investors. Among the 12 themes are “The humanization of pets,” “The experience economy,” and our newest one, “A healthier tomorrow.” All of our themes represent exciting multiyear trends that we believe can drive sustained growth for many businesses. But finding the best companies requires much more than just “fishing in the right ponds.” Success involves digging into individual company fundamentals, their business models, and the structure of their markets. It also requires an element of research that many investors don’t consider: Looking beyond growth potential to analyze the vulnerabilities of a business and potential downside risks.
The growth potential in “enablers”
In our view, it’s not enough to simply identify a business that is associated with a long-term growth theme. We scrutinize businesses in the context of their industries overall, and often we favor the “enablers” of growth themes and trends. Also known as “pick-and-shovel” businesses, these companies provide products or services that enable the growth of the overall industry. Examples in our portfolio include:
Theme: 5G connectivity | Stock: American Tower
The transition to 5G technology is an important growth theme that we believe will play out in waves globally over the next 15 years. Within this theme, we own American Tower, which rents space on towers and rooftop antennas to wireless carriers and broadcasters. This company is indifferent to which mobile provider will gain the most market share, which might be a challenge to accurately predict. Instead, American Tower stands to benefit from the $30 billion-plus in infrastructure that’s necessary to transition from 4G LTE to 5G.
Theme: Personalized medicine | Stock: Lonza
Personalized medicine refers to the customization of medical treatments based on an individual’s specific needs and genetic makeup. We believe we’re in the early innings of a broad shift to personalized medicine. Many companies are making great strides in cell and gene therapy, with thousands of treatments in various phases of development.
However, when it comes to biopharmaceuticals, there are many complexities, uncertainties, and possible outcomes. Rather than trying to forecast which individual drugs and treatments will be successful, we are invested in Lonza, a company that opened the world’s largest dedicated cell-and-gene-therapy facility for businesses that are developing drugs. Lonza is the outsourced manufacturer for over 1,000 different therapies across modalities. We believe Lonza should benefit as any of these treatments successfully come to market.
We dig deep on downside risk
Before any company enters our portfolio, we need to know what could go wrong with the business. We analyze each company’s vulnerabilities and, when possible, assess how it has performed through difficult times in the past. We also discuss this with management teams of the companies themselves. We analyze the range of operational and financial outcomes for a business. To help manage risk at the portfolio level, we target companies with a narrow range of outcomes and we prefer capital-light businesses.
Risk management is particularly important in cyclical industries that are heavily influenced by economic shifts. The semiconductor industry is a good example, and Cadence Design Systems, a stock we own, shows how we approach cyclical challenges:
Cadence Design Systems
- Cadence provides chip-design software and hardware to semiconductor companies
- While its end market is highly cyclical, Cadence benefits from R&D spending by chip companies, which tends to see consistent growth, even through market downcycles
- Chip companies are compelled to continue spending on the next generation of chips, keeping demand growth steady for Cadence
- In 2008 and 2009, Cadence was able to grow despite incredible macroeconomic stress and end market weakness for semiconductors
- Cadence is a key enabler of the semiconductor industry, and allows us to invest in the attractive long-term growth potential in semiconductors with less cyclical risk
We develop new themes to pursue new opportunities
The themes in our portfolio do not change often because they are based on secular trends and our multiyear outlooks. However, we are constantly considering new ones based on changing markets and consumer preferences. To that end, our newest theme is “A healthier tomorrow.” Across the globe, people are prioritizing exercise, diet, and environmental health, and they want greater access to and control over their personal health data.
What’s exciting is that this theme encompasses many different industries, including hospital operators, HVAC equipment manufacturers, medical device makers, and workout apparel and skincare brands. We expect demographic trends to drive increased awareness of this theme, and we anticipate that public policy can further support growth in these markets.
We believe great companies can become even better in challenging markets.
Preparing for slowing macroeconomic growth
There is no question that large-cap growth stocks have struggled in this year’s difficult macroeconomic environment. But we believe great companies can become even better in challenging markets. In periods when growth becomes scarce, we want to own businesses that are unique, with strong balance sheets and revenue visibility. We look for companies that are competitively advantaged, are market share gainers, and have customers that depend heavily on them. We want businesses with the ability to grow at above-market rates and to sustain that growth across an economic cycle. In our view, these are the companies that will distinguish themselves from the competition and the stocks that are most likely to return to favor.
For illustrative purposes only. These are a few examples of current growth themes. Growth themes will change over time. growth potential may not be realized and there is no guarantee of investment success or positive performance. Growth stocks may be more susceptible to earnings disappointments, and the market may not favor growth-style investing. Investors should carefully consider the risk involved before deciding to invest. As with any investment, there is a potential for profit as well as the possibility of loss.
Stock examples: Mention of individual companies are intended to illustrate growth investment themes and should not be considered a recommendation or solicitation to purchase or sell the securities. Current investment themes and individual companies were selected without regard to whether such themes, or relevant securities, were profitable and are intended to help illustrate the investment process. The securities mentioned are not necessarily held by Putnam for all client portfolios. It should not be assumed that any investment in these securities was, or will prove to be, profitable, or that the investment decisions we make in the future will be profitable or equal to the investment performance of securities referenced herein. A security may be selected for the portfolio based on factors other than the growth themes, metrics, and characteristics highlighted herein, and the analysis is not intended to be relied upon as a forecast or investment advice, and is not a recommendation, offer, or solicitation to buy or sell any securities or to adopt any investment strategy. Putnam U.S. Large Cap Growth Equity as of 6/30/22: American Tower (2.00%); Lonza Group (0.71%); Cadence Design Systems (1.72%). Portfolio characteristics are for a representative account within the U.S. Large Cap Growth Equity Composite. Each account is managed individually. Accordingly, account characteristics may vary.
This material is prepared for use by institutional investors and investment professionals and is provided for limited purposes. By receiving and reviewing this material, the recipient acknowledges the following: This material is a general communication being provided for informational and educational purposes only. It is not designed to be a recommendation of any specific investment product, strategy, or decision, and is not intended to suggest taking or refraining from any course of action. The material was not prepared, and is not intended, to address the needs, circumstances, and objectives of any specific institution, plan, or individual(s). Putnam is not providing advice in a fiduciary capacity under applicable law in providing this material, which should not be viewed as impartial, because it is provided as part of the general marketing and advertising activities of Putnam, which earns fees when clients select its products and services. The views and strategies described herein may not be suitable for all investors. Prior to making any investment or financial decisions, any recipients of this material should seek individualized advice from their personal financial, legal, tax, and other professional advisors that takes into account all of the particular facts and circumstances of their situation. Generally, the representative account is selected based on the account that has the longest track record or that is most representative of the intended strategy taking into consideration the account with the least investment restrictions, the size of the account, and/or most relevant and applicable to the prospective client. Representative accounts may change over time. Unless otherwise noted, Putnam is the source of all data. Putnam Investments cannot guarantee the accuracy or completeness of any statements or data contained in the material. Predictions, opinions, and other information contained in this material are subject to change. Any forward-looking statements speak only as of the date they are made, and Putnam assumes no duty to update them. Forward-looking statements are subject to numerous assumptions, risks, and uncertainties. Actual results could differ materially from those anticipated. While Putnam Investments seeks to achieve the portfolio's stated objective, there is no guarantee the objective will be achieved. All investments involve risk, and investment recommendations will not always be profitable. Putnam Investments does not guarantee any minimum level of investment performance or the success of any investment strategy. Investing entails risks, including possible loss of principal. Past performance is no guarantee of future results.
This material or any portion hereof may not be reprinted, sold, or redistributed in whole or in part without the express written consent of Putnam Investments. The information provided relates to Putnam Investments and its affiliates, which include The Putnam Advisory Company, LLC and Putnam Investments Limited®.